Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions
GH Giornelli, P Mando - Clinical Cancer Drugs, 2018 - ingentaconnect.com
Background: Poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors have
entered into the clinic rapidly and are becoming a powerful therapeutic tool, especially in the …
entered into the clinic rapidly and are becoming a powerful therapeutic tool, especially in the …
[PDF][PDF] Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions
GH Giornelli, P Mando - academia.edu
Background: Poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitors have
entered into the clinic rapidly and are becoming a powerful therapeutic tool, especially in the …
entered into the clinic rapidly and are becoming a powerful therapeutic tool, especially in the …